Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 33-48 of 94
Jeffrey L. Neul, MD, PhD
Jeffrey L. Neul, MD, PhD
Alan K. Percy, MD
Alan K. Percy, MD
Jeffrey L. Neul, MD, PhD
Jeffrey L. Neul, MD, PhD
Jeffrey L. Neul, MD, PhD
Alan K. Percy, MD
Jeffrey L. Neul, MD, PhD
Alan K. Percy, MD
James Galvin, MD, MPH, FANA
Gloria Chiang, MD
Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF
Charles P. Vega, MD
- NeuroFrontiers
Advances in Temporal Lobe Epilepsy Research
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Sanjay Kumar, PhD
- NeuroFrontiers
AI in Neurology: What Tools Are Emerging?
Jerome Lisk, MD
Mark Mintz, MD
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Zachary Marcum, PharmD, PhD
- NeuroFrontiers
B-Cell Therapy: When Is It Right for Our MS Patients?
Charles Turck, PharmD, BCPS, BCCCP
Andrew Chan, MD
- NeuroFrontiers
Alzheimer’s Disease: What’s The Latest Research?
Jerome Lisk, MD
Peter Whitehouse, MD, PhD
Daniel George, MSc, PhD
Jerome Lisk, MD
Peter Whitehouse, MD, PhD